Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.2300
-0.0100 (-4.17%)
Aug 1, 2025, 4:10 PM AEST
Paycor HCM Market Cap
Amplia Therapeutics has a market cap or net worth of 89.62 million as of August 1, 2025. Its market cap has increased by 449.96% in one year.
Market Cap
89.62M
Enterprise Value
78.78M
Revenue
3.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.23
Market Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 89.62M, an increase of 159.81%. That is a compound annual growth rate of 8.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 89.62M | 159.57% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | 0.00% |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | 25.79M | 623.82% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.17B |
| Pro Medicus | 33.63B |
| Cochlear | 20.83B |
| Sonic Healthcare | 13.65B |
| Ramsay Health Care | 8.91B |
| Telix Pharmaceuticals | 7.12B |
| Ansell | 4.38B |
| Mesoblast | 3.13B |